Table 3:
Endpoints with implications for evaluating trials in clinical nutrition | Examples |
---|---|
Biomedical endpoint (BM) | e.g. improvement of body weight, body composition, morbidity, mortality |
Patient-centered/-reported endpoint (PC) | e.g. validated quality-of-life score |
Health economic endpoint (HE) | e.g. QALYs or budget savings |
Decision-making endpoint (DM) | e.g. clinical parameters or biomarkers that allow to make a clinically relevant decision such as transfer from ICU to a normal ward or nutritional support yes/no |
Integration of classical and patient-reported endpoint (IE) | The combination of BM and PC, e.g. complex scores such as the Frailty Index |
Adapted from Koller et al. (9)